MannKind Corporation (MNKD) Financials
MNKD Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 475.2 million | 721.4 million |
2023-09-30 | 320.3 million | 572.1 million |
2023-06-30 | 313.4 million | 573.9 million |
2023-03-31 | 298.1 million | 553.5 million |
MNKD Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 15.8 million | 3.8 million |
2023-09-30 | -2.7 million | 4.6 million |
2023-06-30 | -14.3 million | 5.6 million |
2023-03-31 | -7.2 million | 3.7 million |
MNKD Net Income
No data available :(
MNKD Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 295.1 million | - | 3.9 million |
2023-09-30 | 141.0 million | - | 4.3 million |
2023-06-30 | 144.3 million | - | 4.6 million |
2023-03-31 | 166.1 million | 225.8 million | 4.9 million |
MNKD Shares Outstanding
MNKD Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 5.9 million | 9.2 million | 9.5 million | 11.0 million |
2023-09-30 | 11.4 million | 10.0 million | 10.5 million | 13.4 million |
2023-06-30 | 16.9 million | 6.5 million | 11.9 million | 14.0 million |
2023-03-31 | 8.3 million | 5.6 million | 10.5 million | 13.3 million |
MNKD Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 58.5 million | 18.1 million |
2023-09-30 | 51.3 million | 14.3 million |
2023-06-30 | 48.6 million | 14.2 million |
2023-03-31 | 40.6 million | 16.2 million |
MNKD
Price: $4.40
52 week price:
Earnings Per Share: -0.04 USD
P/E Ratio: -28.83
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.9 million
Ebitda: -28.5 millionMarket Capitalization: 1.2 billion